Zhejiang Shengda Bio-Pharm Co., Ltd.SSE: 603079

(603079)"Zhejiang Shengda Bio-Pharm Co., Ltd."Announcement on Progress in Using Idle Raised Funds for Cash Management

· Issued by Zhejiang Shengda Bio-Pharm Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603079 · · 6 pages · Chinese

Summary by 6ix AI

Zhejiang Shengda Bio-Pharm Co., Ltd. has announced progress regarding the use of idle raised funds for cash management. The company plans to invest a significant amount in low-risk financial products to enhance the efficiency of its idle funds. The filing includes details on the investment procedures, risk analysis, and the expected impact on the company's operations. The board has approved the use of these funds, ensuring compliance with relevant regulations.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603079zhejiang-shengda-bio-pharm-co-ltdannouncement-on-progress-in-using-idle-raised-funds-for-cash-management-1

Release

Announcement on Progress in Using Idle Raised Funds for Cash Management

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Zhejiang Shengda Bio-Pharm Co., Ltd. on 6ix

Story so far

Earlier from Zhejiang Shengda Bio-Pharm

All Zhejiang Shengda Bio-Pharm news releases